InvestorsHub Logo
Followers 10
Posts 569
Boards Moderated 1
Alias Born 02/12/2021

Re: None

Sunday, 10/03/2021 10:57:04 PM

Sunday, October 03, 2021 10:57:04 PM

Post# of 44690
Evidently still problems with Merkmectin, and hot on its heels Fizermectin, which is ANOTHER Protease Inhibitor, like Ivermectin, which is used by 1.3 BILLION people in India.
APPROVAL OF AVIPTADIL/ZYESAMI IS NEEDED QUICKLY....FDA IS STARTING TO LOOK LIKE ITS BEEN ASLEEP UP TO THIS POINT .


https://www.zerohedge.com/news/2021-10-01/mercks-therapeutics-waiting-wings-faucis-removal

Merck's Molnupiravir News
This is a drug with known mutagenicity. Ironically Merck’s inclusion criteria in ALL their clinical trials required participants to not have sex. This includes the clinical trial for prophylaxis. Perhaps they want to avoid the potential of birth defects so this drug is clearly not going to appeal to anyone building a family or engaging in intercourse.

From HIV/AIDS to COVID-19: Vaccines Fail to Impress
The government has a very flawed strategy that the vaccines will fix all.

Therapy Ignorance Costing American Lives and Trillions of Dollars

My opinion is reflected in my posts, and it is never advice to buy, sell or trade any securities. Do your own due diligence before purchasing anything in the stock market.